InSyBio is a biotechnology pioneer company (www.insybio.com) in personalized healthcare and nutrition which focuses on developing computational frameworks and tools for the analysis of complex life-science and biological data. The key objective of our analysis lies in the discovery of predictive integrated biosignatures (biomarkers of various categories) and models with increased prognostic and diagnostic aspects for personalized Healthcare and Nutrition Industries. InSyBio has developed an on-line suite of software tools – called InSyBio Suite – which assists biology researchers in extracting valuable biological knowledge from experimental data. Our customers are biology researchers working in academic, BioPharma and applied research laboratories which need bioinformatics tools and services for preprocessing and analyzing their data. Existing solutions, provided by academic and commercial bioinformatics products and services, are specific task-oriented, costly and time consuming. In contrast, InSyBio Suite consists of tools for providing integrated biological information from various sources, while at the same time it is empowered with robust, user-friendly and installation-free bioinformatics tools based on intelligent algorithms and methods. Some of its methodologies have already been published in international scientific journals and conferences while others are under submission for patent approval by its members. Using InSyBio Suite, biology researchers can save time and a significant amount of money. The 3 and 12-month licenses of the Suite of Products will be sold via internet and direct sales utilizing all available tools to reach out to target groups. Since June 2015 InSyBio participates in NBG Business Seeds program by National Bank of Greece. For more information about our company contact us at info@insybio.com.